ADA Scientific Sessions 2026 Abstract
IGlarLixi Improves PPG and DTIR in Asian People with T2D (PwT2D): Post Hoc Pooled Analysis of Ph3 Studies
Trial in peopleInterventions
Papers by Felipe Lauand
5 results
- ADA Scientific Sessions 2026 Abstract
Impact of IGlarLixi on Glycemic Variability (GV): A Participant-Level Exploratory Pooled Analysis of the Global LixiLan Clinical Trial Program
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Glycemic Outcomes When Switching to iGlarLixi from Premixed Insulin (PI) in People with Type 2 Diabetes (T2D) by iGlarLixi Pen Subgroups—Post Hoc Analysis of Soli-SWITCH
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Early Glycemic Improvement When Switching to iGlarLixi from Premixed Insulins (PI) in Adults with Type 2 Diabetes (T2D)—A Post Hoc Analysis of Soli-SWITCH
Trial in peopleInterventions
- ADA Scientific Sessions 2025 Abstract
Impact of Time of Injection Comparing iGlarLixi vs. IDegAsp in Chinese People with Type 2 Diabetes—Exploratory Analysis of the SoliD Study
Trial in peopleInterventions